CLVT — Clarivate Plc

Summary of Clarivate's Q4 2025 Earnings Call

1. Key Financial Results and Metrics

• Q4 Revenue: $617 million; Full Year Revenue: $2.455 billion (entirely inorganic due to divestitures).
• Net Income: $3 million for Q4, a $195 million improvement year-over-year; Full Year Improvement: $436 million, driven by the absence of prior year impairment charges.
• Adjusted EBITDA: Over $1 billion for the year; Free Cash Flow: $365 million, representing a 2% increase year-over-year.
• Organic Annual Contract Value (ACV) Growth: Nearly 2% in 2025, with 88% of revenue from organic recurring sources.
• Retention Rate: Stable at 93%.

2. Strategic Updates and Business Highlights

• Clarivate is undergoing a strategic review and has initiated a process to sell its Life Sciences & Health (LS&H) business to focus on Academia & Government (A&G) and Intellectual Property (IP) segments.
• The company has launched 12 major AI-powered products and features, enhancing its market position.
• AI is viewed as an amplifier of business capabilities rather than a disruption, with 97% of revenue derived from proprietary solutions.
• The A&G segment achieved 2% organic ACV growth despite funding headwinds, while the IP segment is expected to return to growth with new leadership and product innovations.

3. Forward Guidance and Outlook

• 2026 Guidance:
  • Organic ACV growth projected at 2% to 3%.
  • Recurring organic revenue growth targeted at 1% to 2%.
  • Free cash flow expected to grow to approximately $400 million (10% increase).
• The company anticipates continued improvement in operational metrics, with a focus on innovation and portfolio rationalization.

4. Bad News, Challenges, or Points of Concern

• The company faces challenges from the ongoing divestiture process, which is expected to lower revenue by approximately $100 million in 2026.
• Organic transactional revenues have declined, impacting overall revenue growth.
• There are concerns regarding AI disruption in the software and information services sector, although management believes their proprietary data and solutions provide a competitive moat.

5. Notable Q&A Insights

• Monetization Model: The subscription model remains varied, with a mix of seat licenses and institutional size influencing pricing. AI innovations are seen as potential upsell opportunities.
• IP Segment Recovery: Management expressed confidence in returning the IP segment to growth, citing new product launches and market recovery indicators.
• Capital Allocation: The company plans to prioritize deleveraging over stock buybacks, despite attractive free cash flow returns, due to a favorable debt structure and market conditions.
• Price Realization: Growth in ACV and recurring revenue is primarily driven by volume rather than price increases, with expectations for continued volume-driven growth in 2026.

Overall, Clarivate is positioned for growth through strategic focus on its core segments and leveraging AI innovations, despite facing challenges from divestitures and market dynamics.